Horizon Technology Finance Corporation has closed a $3 million venture loan for GenePeeks, a genetic information company focused on reproductive risk prediction. GenePeeks will use the funds to support its continued growth.

"GenePeeks has developed a groundbreaking technology that predicts heritable disease risk with superior breadth and sensitivity," stated Gerald A. Michaud, President of Horizon. "We are pleased to support GenePeeks with venture financing and believe the company's innovative patented technology provides GenePeeks with significant long-term growth potential in the rapidly growing genetic screening market."

Anne Morriss, CEO of GenePeeks, stated, "The growth capital with attractive terms provided by Horizon helps to unlock our potential for impact at a very important stage for the company. We appreciate the support and confidence of the Horizon team as we continue to make progress and help families protect their children from hundreds of life-threatening and life-altering conditions."

Horizon Technology Finance Corporation is a business development company that provides secured loans to development-stage companies backed by established venture capital and private equity firms within the technology, life science, healthcare information and services, and cleantech industries.